{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:28:24Z","timestamp":1793680104713,"version":"4.5.1"},"reference-count":96,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNR"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Hyperprolactinemia, characterized by persistently elevated serum prolactin levels, is traditionally associated with reproductive and metabolic disturbances. Emerging\nevidence now implicates hyperprolactinemia in central nervous system dysfunction, particularly in\nthe pathogenesis of neurodegenerative disorders. Chronic elevation of prolactin has been linked to\ntau pathology, a hallmark of Alzheimer\u2019s disease and related tauopathies, through mechanisms\nthat promote tau hyperphosphorylation, microtubule destabilization, and neuronal compromise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>This systematic review assesses the evidence on hyperprolactinemia and tau pathology. The overall literature search was performed in PubMed, Scopus, and Web of Science with\nthe help of certain keywords that included prolactin, tau protein, neuroinflammation, oxidative\nstress, and dopaminergic signaling. The studies were narrowed down to a set of pre-established inclusion and exclusion criteria (original research, molecular and clinical data, relevance to neuropsychiatric disorders, non-English articles, reviews, animal studies that did not have a translational relevance). A clear study selection procedure was used, with independent screening and\nconsensus-based resolution. The results generalize molecular, transcriptomic, neuroimaging, and\nclinical data to assess mechanistic connections and treatment prospects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Neurons susceptible to tau accumulation under hyperprolactinemic states exhibit altered\napoptotic signaling, impaired vesicular trafficking, and mitochondrial dysfunction. These disruptions correlate with increased neuroinflammation and oxidative stress, suggesting a mechanistic\nlink between endocrine imbalance and tau-mediated neurotoxicity. Therapeutic agents such as dopamine agonists, selective kinase inhibitors, and prolactin receptor antagonists have the potential\nto restore neuroendocrine homeostasis and mitigate tau pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The findings underscore hyperprolactinemia as a modifiable risk factor for cognitive\ndecline. The neuroendocrine-tau axis represents a critical interface where hormonal dysregulation\nmay precipitate neurodegenerative cascades. Clinical implications in the manuscript include that\nprolactin may serve as a biomarker of an early neurodegenerative process and that its role in the\ntreatment approach includes dopamine agonists, prolactin receptor antagonists, and kinase inhibitors. This simplified methodology will ensure the highlights are original and have translational implications beyond mere abstract repetition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Hyperprolactinemia-induced tau dysregulation presents novel opportunities for neuroprotective targeting. By bridging molecular mechanisms with clinical relevance, this review advocates for longitudinal studies to assess cognitive outcomes in hyperprolactinemic individuals. Emphasizing endocrine health may enhance cognitive resilience and inform future strategies for diagnosis, risk stratification, and therapeutic intervention in neurodegenerative diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115672026467094260417052012","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:49:01Z","timestamp":1778658541000},"page":"315-326","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperprolactinemia and Tau Pathology: Unravelling Neuroendocrine Dysregulation for Therapeutic Targeting"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4423-6819","authenticated-orcid":true,"given":"Prashant","family":"Tiwari","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru South, 562112, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Kadiri","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru South, 562112, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunjbihari","family":"Sulakhiya","sequence":"additional","affiliation":[{"name":"Department ofPharmacy, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh, 484887, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.bcp.2023.115522","volume":"211","author":"Monteiro A.R.","year":"2023","unstructured":"Monteiro A.R.; Barbosa D.J.; Remi\u00e3o F.; Silva R.; Alzheimer\u2019s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol  2023,211,115522","journal-title":"Biochem Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s11154-024-09906-9","volume":"25","author":"Finn B.P.","year":"2024","unstructured":"Finn B.P.; Dattani M.T.; The molecular basis of hypoprolactinaemia. Rev Endocr Metab Disord  2024,25(6),967-983","journal-title":"Rev Endocr Metab Disord"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e70048","DOI":"10.1002\/alz.70048","volume":"21","author":"Wang L.","year":"2025","unstructured":"Wang L.; Sooram B.; Kumar R.; Schedin-Weiss S.; Tjernberg L.O.; Winblad B.; Tau degradation in Alzheimer\u2019s disease: Mechanisms and therapeutic opportunities. Alzheimers Dement  2025,21(3),e70048","journal-title":"Alzheimers Dement"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"170425","DOI":"10.1016\/j.peptides.2020.170425","volume":"135","author":"Anagnostou I.","year":"2021","unstructured":"Anagnostou I.; Mu\u00f1oz-Mayorga D.; Morales T.; Prolactin neuroprotective action against excitotoxic insult in the hippocampus of male mice. Peptides  2021,135,170425","journal-title":"Peptides"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","volume":"185","author":"Tracy T.E.","year":"2022","unstructured":"Tracy T.E.; Madero-P\u00e9rez J.; Swaney D.L.; Chang T.S.; Moritz M.; Konrad C.; Ward M.E.; Stevenson E.; H\u00fcttenhain R.; Kauwe G.; Mercedes M.; Sweetland-Martin L.; Chen X.; Mok S.A.; Wong M.Y.; Telpoukhovskaia M.; Min S.W.; Wang C.; Sohn P.D.; Martin J.; Zhou Y.; Luo W.; Trojanowski J.Q.; Lee V.M.Y.; Gong S.; Manfredi G.; Coppola G.; Krogan N.J.; Geschwind D.H.; Gan L.; Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell  2022,185(4),712-728.e14","journal-title":"Cell"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4103\/NRR.NRR-D-24-00230","volume":"20","author":"Zhang Y.","year":"2025","unstructured":"Zhang Y.; Liang Y.; Gu Y.; The dopaminergic system and Alzheimer\u2019s disease. Neural Regen Res  2025,20(9),2495-2512","journal-title":"Neural Regen Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e70960","DOI":"10.1002\/brb3.70960","volume":"15","author":"Ma X.","year":"2025","unstructured":"Ma X.; Lu Y.; Xu Y.; Guo S.; Wang W.; Shang W.; Qiu W.; Wang P.; Shu Y.; Wang Y.; Elevated Prolactin Levels Are Associated With Increased Severity and Psychiatric Symptoms in Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Brain Behav  2025,15(11),e70960","journal-title":"Brain Behav"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"124548","DOI":"10.1016\/j.wneu.2025.124548","volume":"204","author":"Ku J.","year":"2025","unstructured":"Ku J.; Li H.; Bao J.; Dai X.; Wang B.; Hormonal Influences on Cognitive Function in Pituitary Neuroendocrine Tumors. World Neurosurg  2025,204,124548","journal-title":"World Neurosurg"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1007\/s00213-022-06232-3","volume":"239","author":"Mou C.Y.","year":"2022","unstructured":"Mou C.Y.; Xie Y.F.; Wei J.X.; Wang Q.Y.; Le J.Y.; Bao Y.J.; Zhang P.P.; Mao Y.C.; Huang X.H.; Pan H.B.; Naman C.B.; Liu L.; Liang H.Z.; Wu X.; Xu J.; Cui W.; Rose Bengal inhibits \u03b2-amyloid oligomers-induced tau hyperphosphorylation via acting on Akt and CDK5 kinases. Psychopharmacology (Berl)  2022,239(11),3579-3593","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"107559","DOI":"10.1016\/j.neuropharm.2019.03.002","volume":"161","author":"Pajarillo E.","year":"2019","unstructured":"Pajarillo E.; Rizor A.; Lee J.; Aschner M.; Lee E.; The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics. Neuropharmacology  2019,161,107559","journal-title":"Neuropharmacology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e13422","DOI":"10.1111\/jne.13422","volume":"36","author":"Liu K.","year":"2024","unstructured":"Liu K.; Zhao J.; Yu H.; Yang J.; Ren Y.; The research trend of hyperprolactinemia from 2011 to 2023 was analyzed by bibliometrics. J Neuroendocrinol  2024,36(9),e13422","journal-title":"J Neuroendocrinol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s40618-024-02471-7","volume":"48","author":"Raut S.","year":"2024","unstructured":"Raut S.; Khambata K.; Singh D.; Balasinor N.H.; Molecular mechanisms underlying the effects of hypo- and hyper-prolactinemia on spermatogenesis and fertility in male rats. J Endocrinol Invest  2024,48(3),743-756","journal-title":"J Endocrinol Invest"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/cells14191506","volume":"14","author":"Shen X.","year":"2025","unstructured":"Shen X.; Li H.; Zhang B.; Li Y.; Zhu Z.; Tau-Targeted Therapeutic Strategies: Mechanistic Targets, Clinical Pipelines, and Analysis of Failures. Cells  2025,14(19),1506","journal-title":"Cells"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"21","author":"Ossenkoppele R.","year":"2022","unstructured":"Ossenkoppele R.; van der Kant R.; Hansson O.; Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol  2022,21(8),726-734","journal-title":"Lancet Neurol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000519552","volume":"29","author":"Duc Nguyen H.","year":"2022","unstructured":"Duc Nguyen H.; Hoang N.M.H.; Ko M.; Seo D.; Kim S.; Jo W.H.; Bae J.W.; Kim M.S.; Association between serum prolactin levels and neurodegenerative diseases: systematic review and meta-analysis. Neuroimmunomodulation  2022,29(2),85-96","journal-title":"Neuroimmunomodulation"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1002\/ehf2.14971","volume":"11","author":"Garcia-Pavia P.","year":"2024","unstructured":"Garcia-Pavia P.; Damy T.; Piriou N.; Barriales-Villa R.; Cappelli F.; Bahus C.; Munteanu C.; Keohane D.; Mallaina P.; Elliott P.; Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy. ESC Heart Fail  2024,11(6),4314-4324","journal-title":"ESC Heart Fail"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"102341","DOI":"10.1016\/j.arr.2024.102341","volume":"98","author":"Zhang F.","year":"2024","unstructured":"Zhang F.; Zhang W.; Research progress in Alzheimer\u2019s disease and bone-brain axis. Ageing Res Rev  2024,98,102341","journal-title":"Ageing Res Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/ph16020312","volume":"16","author":"Lazarev V.F.","year":"2023","unstructured":"Lazarev V.F.; Dutysheva E.A.; Kanunikov I.E.; Guzhova I.V.; Margulis B.A.; Protein Interactome of Amyloid-\u03b2 as a Therapeutic Target. Pharmaceuticals (Basel)  2023,16(2),312","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13024-022-00586-0","volume":"17","author":"Gobom J.","year":"2022","unstructured":"Gobom J.; Benedet A.L.; Mattsson-Carlgren N.; Montoliu-Gaya L.; Schultz N.; Ashton N.J.; Janelidze S.; Servaes S.; Sauer M.; Pascoal T.A.; Karikari T.K.; Lantero-Rodriguez J.; Brinkmalm G.; Zetterberg H.; Hansson O.; Rosa-Neto P.; Blennow K.; Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer\u2019s disease continuum. Mol Neurodegener  2022,17(1),81","journal-title":"Mol Neurodegener"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.21037\/tau-23-397","volume":"13","author":"Atmoko W.","year":"2024","unstructured":"Atmoko W.; Savira M.; Shah R.; Chung E.; Agarwal A.; Isolated teratozoospermia: revisiting its relevance in male infertility: a narrative review. Transl Androl Urol  2024,13(2),260-273","journal-title":"Transl Androl Urol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"eabb8255","DOI":"10.1126\/science.abb8255","volume":"371","author":"Chang C.W.","year":"2021","unstructured":"Chang C.W.; Shao E.; Mucke L.; Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies. Science  2021,371(6532),eabb8255","journal-title":"Science"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4103\/apjtb.apjtb_192_24","volume":"14","author":"Arya R.","year":"2024","unstructured":"Arya R.; Jain S.; Paliwal S.; Madan K.; Sharma S.; Mishra A.; Tiwari P.; Kadiri S.K.; BACE1 inhibitors: A promising therapeutic approach for the management of Alzheimer\u2019s disease. Asian Pac J Trop Biomed  2024,14(9),369-381","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"ENEURO.0503-22.2023","DOI":"10.1523\/ENEURO.0503-22.2023","volume":"10","author":"Betters RK","year":"2023","unstructured":"Betters RK; Luhmann E; Gottschalk AC; Xu Z; Shin MR; Ptak CP; Fiock KL; Radoshevich LC; Hefti MM; Characterization of the tau interactome in human brain reveals isoform-dependent interaction with 14-3-3 family proteins. eNeuro  2023,10(3),ENEURO.0503-22.2023","journal-title":"eNeuro"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"112796","DOI":"10.1016\/j.celrep.2023.112796","volume":"42","author":"Xu S.","year":"2023","unstructured":"Xu S.; Suttapitugsakul S.; Tong M.; Wu R.; Systematic analysis of the impact of phosphorylation and O-GlcNAcylation on protein subcellular localization. Cell Rep  2023,42(7),112796","journal-title":"Cell Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","volume":"45","author":"Wangchuk P.","year":"2024","unstructured":"Wangchuk P.; Yeshi K.; Loukas A.; Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol Sci  2024,45(10),892-903","journal-title":"Trends Pharmacol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303352625250526073105","author":"Kadiri S.K.","year":"2025","unstructured":"Kadiri S.K.; Tiwari P.; Khobragade D.S.; B S D.G.; Rout S.K.; Neuroendocrine Effects of Hyperprolactinemia: Focus on Dopamine and Serotonin Systems. Endocr Metab Immune Disord Drug Targets  Epub ahead of print2025","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.3390\/ijms26125909","volume":"26","author":"Kraus V.","year":"2025","unstructured":"Kraus V.; \u010ci\u017em\u00e1rov\u00e1 B.; Birkov\u00e1 A.; When Your Body Tells You to Not Breastfeed\u2014The Connivance of Oxytocin, Prolactin, and Dopamine. Int J Mol Sci  2025,26(12),5909","journal-title":"Int J Mol Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s42000-022-00373-y","volume":"21","author":"Rana M.","year":"2022","unstructured":"Rana M.; Jain S.; Choubey P.; Prolactin and its significance in the placenta. Hormones (Athens)  2022,21(2),209-219","journal-title":"Hormones (Athens)"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e70098","DOI":"10.1111\/jne.70098","volume":"37","author":"Hjelholt A.J.","year":"2025","unstructured":"Hjelholt A.J.; Tei R.M.H.; Diener H.C.; J\u00f8rgensen J.O.L.; Dopamine and prolactin in migraine: Mechanisms and potential therapeutic targets. J Neuroendocrinol  2025,37(12),e70098","journal-title":"J Neuroendocrinol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/03331024211039813","volume":"42","author":"Ikegami D.","year":"2022","unstructured":"Ikegami D.; Navratilova E.; Yue X.; Moutal A.; Kopruszinski C.M.; Khanna R.; Patwardhan A.; Dodick D.W.; Porreca F.; A prolactin-dependent sexually dimorphic mechanism of migraine chronification. Cephalalgia  2022,42(3),197-208","journal-title":"Cephalalgia"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1134\/S1068162024060189","volume":"50","author":"Vishnumurthy R.H.","year":"2024","unstructured":"Vishnumurthy R.H.; Priya M.G.R.; Tiwari P.; Solomon V.R.; Cognitive Improvement Effects of Polymer-Based Microencapsulated Celecoxib in a Rat Model of Alzheimer\u2019s Disease. Russ J Bioorganic Chem  2024,50(6),2312-2324","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1038\/s41418-022-01027-7","volume":"29","author":"Xie W.","year":"2022","unstructured":"Xie W.; Guo D.; Li J.; Yue L.; Kang Q.; Chen G.; Zhou T.; Wang H.; Zhuang K.; Leng L.; Li H.; Chen Z.; Gao W.; Zhang J.; CEND1 deficiency induces mitochondrial dysfunction and cognitive impairment in Alzheimer\u2019s disease. Cell Death Differ  2022,29(12),2417-2428","journal-title":"Cell Death Differ"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41573-024-01105-0","volume":"24","author":"Antico O.","year":"2025","unstructured":"Antico O.; Thompson P.W.; Hertz N.T.; Muqit M.M.K.; Parton L.E.; Targeting mitophagy in neurodegenerative diseases. Nat Rev Drug Discov  2025,24(4),276-299","journal-title":"Nat Rev Drug Discov"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3390\/nu15071737","volume":"15","author":"Chu C.","year":"2023","unstructured":"Chu C.; Yu L.; Li Y.; Guo H.; Zhai Q.; Chen W.; Tian F.; Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson\u2019s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis. Nutrients  2023,15(7),1737","journal-title":"Nutrients"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1518868","DOI":"10.3389\/fnmol.2025.1518868","volume":"18","author":"Shaikh A.","year":"2025","unstructured":"Shaikh A.; Ahmad F.; Teoh S.L.; Kumar J.; Yahaya M.F.; Neurotrophic factor alpha 1 gene therapy in Alzheimer\u2019s disease: scope and advancements. Front Mol Neurosci  2025,18,1518868","journal-title":"Front Mol Neurosci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1567205014666170417111859","volume":"15","author":"Gao Y.","year":"2018","unstructured":"Gao Y.; Tan L.; Yu J.T.; Tan L.; Tau in Alzheimer\u2019s Disease: Mechanisms and Therapeutic Strategies. Curr Alzheimer Res  2018,15(3),283-300","journal-title":"Curr Alzheimer Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.3390\/ijms24065574","volume":"24","author":"Kawahata I.","year":"2023","unstructured":"Kawahata I.; Fukunaga K.; Protein Kinases and Neurodegenerative Diseases. Int J Mol Sci  2023,24(6),5574","journal-title":"Int J Mol Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.3390\/ijms21176127","volume":"21","author":"Ghemrawi R.","year":"2020","unstructured":"Ghemrawi R.; Khair M.; Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases. Int J Mol Sci  2020,21(17),6127","journal-title":"Int J Mol Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","volume":"10","author":"Pellarin I.","year":"2025","unstructured":"Pellarin I.; Dall\u2019Acqua A.; Favero A.; Segatto I.; Rossi V.; Crestan N.; Karimbayli J.; Belletti B.; Baldassarre G.; Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. Signal Transduct Target Ther  2025,10(1),11","journal-title":"Signal Transduct Target Ther"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","volume":"25","author":"Parra Bravo C.","year":"2024","unstructured":"Parra Bravo C.; Naguib S.A.; Gan L.; Cellular and pathological functions of tau. Nat Rev Mol Cell Biol  2024,25(11),845-864","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.2174\/0115748855341835250120064444","volume":"20","author":"Tiwari P.","year":"2025","unstructured":"Tiwari P.; Kadiri S.K.; Khobragade D.S.; Dubey S.; GluN2B of NMDA Receptor and Calmodulin: Balanced Calcium Regulation to Combat Alzheimer\u2019s Disease. Curr Drug Ther  2025,20","journal-title":"Curr Drug Ther"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1016\/j.cell.2023.07.027","volume":"186","author":"Hahn O.","year":"2023","unstructured":"Hahn O.; Foltz A.G.; Atkins M.; Kedir B.; Moran-Losada P.; Guldner I.H.; Munson C.; Kern F.; P\u00e1lovics R.; Lu N.; Zhang H.; Kaur A.; Hull J.; Huguenard J.R.; Gr\u00f6nke S.; Lehallier B.; Partridge L.; Keller A.; Wyss-Coray T.; Atlas of the aging mouse brain reveals white matter as vulnerable foci. Cell  2023,186(19),4117-4133.e22","journal-title":"Cell"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tcb.2022.01.011","volume":"32","author":"Boyko S.","year":"2022","unstructured":"Boyko S.; Surewicz W.K.; Tau liquid\u2013liquid phase separation in neurodegenerative diseases. Trends Cell Biol  2022,32(7),611-623","journal-title":"Trends Cell Biol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e70234","DOI":"10.1002\/hbm.70234","volume":"46","author":"Jafarian A.","year":"2025","unstructured":"Jafarian A.; Assem M.K.; Kocagoncu E.; Lanskey J.H.; Fye H.; Williams R.; Quinn A.J.; Pitt J.; Raymont V.; Lowe S.; Singh K.D.; Woolrich M.; Nobre A.C.; Henson R.N.; Friston K.J.; Rowe J.B.; Neurophysiological Progression in Alzheimer\u2019s Disease: Insights From Dynamic Causal Modelling of Longitudinal Magnetoencephalography. Hum Brain Mapp  2025,46(8),e70234","journal-title":"Hum Brain Mapp"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1111\/febs.16055","volume":"289","author":"Polanco J.C.","year":"2022","unstructured":"Polanco J.C.; G\u00f6tz J.; Exosomal and vesicle-free tau seeds-propagation and convergence in endolysosomal permeabilization. FEBS J  2022,289(22),6891-6907","journal-title":"FEBS J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells8050488","volume":"8","author":"Reddy P.H.","year":"2019","unstructured":"Reddy P.H.; Oliver D.M.A.; Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer\u2019s Disease. Cells  2019,8(5),488","journal-title":"Cells"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s41556-024-01461-4","volume":"26","author":"Zhou J.","year":"2024","unstructured":"Zhou J.; Chuang Y.; Redding-Ochoa J.; Zhang R.; Platero A.J.; Barrett A.H.; Troncoso J.C.; Worley P.F.; Zhang W.; The autophagy adaptor TRIAD3A promotes tau fibrillation by nested phase separation. Nat Cell Biol  2024,26(8),1274-1286","journal-title":"Nat Cell Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"130305","DOI":"10.1016\/j.bmcl.2025.130305","volume":"127","author":"Spinelli R.","year":"2025","unstructured":"Spinelli R.; Sanch\u00eds I.; Siano A.; Fighting Alzheimer\u2019s naturally: Peptides as multitarget drug leads. Bioorg Med Chem Lett  2025,127,130305","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40263-019-00658-8","volume":"33","author":"Lanzillotta C.","year":"2019","unstructured":"Lanzillotta C.; Di Domenico F.; Perluigi M.; Butterfield D.A.; Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives. CNS Drugs  2019,33(10),957-969","journal-title":"CNS Drugs"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e70533","DOI":"10.1002\/alz.70533","volume":"21","author":"S\u00e1rk\u00e1ny Z.","year":"2025","unstructured":"S\u00e1rk\u00e1ny Z.; Dam\u00e1sio J.; Macedo-Ribeiro S.; Martins P.M.; Reply to \u201cReconsidering dopaminergic modulation in Alzheimer\u2019s disease: A case for levodopa\/carbidopa as a disease-modifying agent\u201d. Alzheimers Dement  2025,21(7),e70533","journal-title":"Alzheimers Dement"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"105738","DOI":"10.1016\/j.archger.2024.105738","volume":"131","author":"Zhou K.G.","year":"2025","unstructured":"Zhou K.G.; Huang Y.B.; Zhu Z.W.; Jiang M.; Jin L.J.; Guan Q.; Tian L.L.; Zhang J.X.; Mesencephalic astrocyte-derived neurotrophic factor inhibits neuroinflammation through autophagy-mediated \u03b1-synuclein degradation. Arch Gerontol Geriatr  2025,131,105738","journal-title":"Arch Gerontol Geriatr"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mcna.2021.08.010","volume":"106","author":"Ciccarone D.","year":"2022","unstructured":"Ciccarone D.; Shoptaw S.; Understanding Stimulant Use and Use Disorders in a New Era. Med Clin North Am  2022,106(1),81-97","journal-title":"Med Clin North Am"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11064-025-04399-7","volume":"50","author":"Sahoo T.A.","year":"2025","unstructured":"Sahoo T.A.; Chand J.; Kandy A.T.; Antony S.; Subramanian G.; Unravelling the Proteinopathic Engagement of \u03b1-Synuclein, Tau, and Amyloid Beta in Parkinson\u2019s Disease: Mitochondrial Collapse as a Pivotal Driver of Neurodegeneration. Neurochem Res  2025,50(3),145","journal-title":"Neurochem Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ibra.12197","volume":"11","author":"Mohapatra T.K.","year":"2025","unstructured":"Mohapatra T.K.; Nayak R.R.; Ganeshpurkar A.; Tiwari P.; Kumar D.; Navigating the treatment landscape of Alzheimer\u2019s disease: Current strategies and future directions. Ibrain  2025,11(2),162-184","journal-title":"Ibrain"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1111\/eci.70042","volume":"55","author":"Kamperdijk L.","year":"2025","unstructured":"Kamperdijk L.; Shkarpa N.; Twickler M.T.B.; The contribution of prolactin in the occurrence of premature cardiovascular disease predominantly through modulating the inflammatory cascade. Eur J Clin Invest  2025,55(8),e70042","journal-title":"Eur J Clin Invest"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/14656566.2023.2216380","volume":"24","author":"Bovenzi R.","year":"2023","unstructured":"Bovenzi R.; Conti M.; Schirinzi T.; Pharmacotherapy for Sydenham\u2019s chorea: where are we and where do we need to be? Expert Opin Pharmacother  2023,24(11),1317-1329","journal-title":"Expert Opin Pharmacother"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jconrel.2024.09.012","volume":"375","author":"Jin Y.","year":"2024","unstructured":"Jin Y.; Du Q.; Song M.; Kang R.; Zhou J.; Zhang H.; Ding Y.; Amyloid-\u03b2-targeting immunotherapies for Alzheimer\u2019s disease. J Control Release  2024,375,346-365","journal-title":"J Control Release"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41586-021-03489-0","volume":"593","author":"Da Mesquita S.","year":"2021","unstructured":"Da Mesquita S.; Papadopoulos Z.; Dykstra T.; Brase L.; Farias F.G.; Wall M.; Jiang H.; Kodira C.D.; de Lima K.A.; Herz J.; Louveau A.; Goldman D.H.; Salvador A.F.; Onengut-Gumuscu S.; Farber E.; Dabhi N.; Kennedy T.; Milam M.G.; Baker W.; Smirnov I.; Rich S.S.; Benitez B.A.; Karch C.M.; Perrin R.J.; Farlow M.; Chhatwal J.P.; Holtzman D.M.; Cruchaga C.; Harari O.; Kipnis J.; Meningeal lymphatics affect microglia responses and anti-A\u03b2 immunotherapy. Nature  2021,593(7858),255-260","journal-title":"Nature"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"13657","DOI":"10.1039\/D2SC03932J","volume":"13","author":"Ramesh M.","year":"2022","unstructured":"Ramesh M.; Govindaraju T.; Multipronged diagnostic and therapeutic strategies for Alzheimer\u2019s disease. Chem Sci (Camb)  2022,13(46),13657-13689","journal-title":"Chem Sci (Camb)"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1212\/WNL.0000000000207193","volume":"101","author":"Alcolea D.","year":"2023","unstructured":"Alcolea D.; Beeri M.S.; Rojas J.C.; Gardner R.C.; Lle\u00f3 A.; Blood Biomarkers in Neurodegenerative Diseases. Neurology  2023,101(4),172-180","journal-title":"Neurology"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"7652","DOI":"10.3390\/ijms26157652","volume":"26","author":"Ezzo M.","year":"2025","unstructured":"Ezzo M.; Etienne-Manneville S.; Microtubule-Targeting Agents: Advances in Tubulin Binding and Small Molecule Therapy for Gliomas and Neurodegenerative Diseases. Int J Mol Sci  2025,26(15),7652","journal-title":"Int J Mol Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/fn.2020.96707","volume":"58","author":"Armstrong R.","year":"2020","unstructured":"Armstrong R.; What causes neurodegenerative disease? Folia Neuropathol  2020,58(2),93-112","journal-title":"Folia Neuropathol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/ijms19102937","volume":"19","author":"Kritsilis M.","year":"2018","unstructured":"Kritsilis M.; V Rizou S.; Koutsoudaki P.N.; Evangelou K.; Gorgoulis V.G.; Papadopoulos D.; Ageing, Cellular Senescence and Neurodegenerative Disease. Int J Mol Sci  2018,19(10),2937","journal-title":"Int J Mol Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.patol.2024.100800","volume":"58","author":"Tarr\u00e1 Marrugo A.D.","year":"2025","unstructured":"Tarr\u00e1 Marrugo A.D.; Histopathological changes of nervous tissue in women over 60 years of age with Alzheimer\u2019s disease and their relationship with menopause. Rev Esp Patol  2025,58(1),100800","journal-title":"Rev Esp Patol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/2305-0500.259171","volume":"8","author":"Tiwari P.","year":"2019","unstructured":"Tiwari P.; Dubey S.; Sahu P.; Tinospora cordifolia attenuates antipsychotic drug induced hyperprolactinemia in Wistar rats. Asian Pac J Reprod  2019,8(3),132-140","journal-title":"Asian Pac J Reprod"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3390\/diagnostics13122118","volume":"13","author":"Dumitriu-Stan R.I.","year":"2023","unstructured":"Dumitriu-Stan R.I.; Burcea I.F.; Salmen T.; Poiana C.; Prognostic Models in Growth-Hormone- and Prolactin-Secreting Pituitary Neuroendocrine Tumors: A Systematic Review. Diagnostics (Basel)  2023,13(12),2118","journal-title":"Diagnostics (Basel)"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ijnp\/pyac031","volume":"25","author":"Fusaroli M.","year":"2022","unstructured":"Fusaroli M.; Raschi E.; Giunchi V.; Menchetti M.; Rimondini Giorgini R.; De Ponti F.; Poluzzi E.; Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System. Int J Neuropsychopharmacol  2022,25(9),727-736","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.3390\/jcm13113098","volume":"13","author":"Tondo G.","year":"2024","unstructured":"Tondo G.; De Marchi F.; Bonardi F.; Menegon F.; Verrini G.; Aprile D.; Anselmi M.; Mazzini L.; Comi C.; Novel Therapeutic Strategies in Alzheimer\u2019s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond. J Clin Med  2024,13(11),3098","journal-title":"J Clin Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11910-017-0779-1","volume":"17","author":"Coughlin D.","year":"2017","unstructured":"Coughlin D.; Irwin D.J.; Emerging Diagnostic and Therapeutic Strategies for Tauopathies. Curr Neurol Neurosci Rep  2017,17(9),72","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"Selkoe D.J.","year":"2016","unstructured":"Selkoe D.J.; Hardy J.; The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med  2016,8(6),595-608","journal-title":"EMBO Mol Med"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"66","DOI":"10.53879\/id.57.01.12021","volume":"57","author":"Tiwari P.","year":"2020","unstructured":"Tiwari P.; Patel N.; Jena S.; Prusty S.K.; Sahu P.K.; Metformin prevents phenytoin induced cognitive impairment. INDIAN DRUGS  2020,57(1),66-71","journal-title":"INDIAN DRUGS"},{"key":"ref=72","author":"Drummond J.B.","year":"2025","unstructured":"Drummond J.B.; Molitch M.E.; Korbonits M.; Prolactinoma Management. Endotext  2025","journal-title":"Endotext"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","volume":"2","author":"Otte C.","year":"2016","unstructured":"Otte C.; Gold S.M.; Penninx B.W.; Pariante C.M.; Etkin A.; Fava M.; Mohr D.C.; Schatzberg A.F.; Major depressive disorder. Nat Rev Dis Primers  2016,2(1),16065","journal-title":"Nat Rev Dis Primers"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2174\/187153032308230427144719","volume":"23","author":"De Vito D.","year":"2023","unstructured":"De Vito D.; Thematic issue: Endocrine, metabolic and immune disorders: A public health issue. Endocr Metab Immune Disord Drug Targets  2023,23(8),1011-1013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"101996","DOI":"10.1016\/j.molmet.2024.101996","volume":"87","author":"Duquenne M.","year":"2024","unstructured":"Duquenne M.; Deligia E.; Folgueira C.; Bourouh C.; Caron E.; Pfrieger F.; Schwaninger M.; Nogueiras R.; Annicotte J.S.; Imbernon M.; Pr\u00e9vot V.; Tanycytic transcytosis inhibition disrupts energy balance, glucose homeostasis and cognitive function in male mice. Mol Metab  2024,87,101996","journal-title":"Mol Metab"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1042\/CS20230317","volume":"138","author":"Barker R.M.","year":"2024","unstructured":"Barker R.M.; Chambers A.; Kehoe P.G.; Rowe E.; Perks C.M.; Untangling the role of tau in sex hormone responsive cancers: lessons learnt from Alzheimer\u2019s disease. Clin Sci (Lond)  2024,138(21),1357-1369","journal-title":"Clin Sci (Lond)"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"10123","DOI":"10.3390\/ijms231710123","volume":"23","author":"Kr\u00f3l-Grzyma\u0142a A.","year":"2022","unstructured":"Kr\u00f3l-Grzyma\u0142a A.; Sienkiewicz-Sz\u0142apka E.; Fiedorowicz E.; Rozmus D.; Cie\u015bli\u0144ska A.; Grzybowski A.; Tear biomarkers in Alzheimer\u2019s and Parkinson\u2019s diseases, and multiple sclerosis: implications for diagnosis (systematic review). Int J Mol Sci  2022,23(17),10123","journal-title":"Int J Mol Sci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00394-023-03267-w","volume":"63","author":"Thomas C.","year":"2024","unstructured":"Thomas C.; Kingshott R.N.; Allott K.M.; Tang J.C.Y.; Dunn R.; Fraser W.D.; Thorley J.; Virgilio N.; Prawitt J.; Hogervorst E.; \u0160karabot J.; Clifford T.; Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active males with sleep complaints. Eur J Nutr  2024,63(1),323-335","journal-title":"Eur J Nutr"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2174\/0109298665391103250825102319","volume":"32","author":"Paul S.","year":"2025","unstructured":"Paul S.; Tiwari P.; Dubey S.; Precision Enzyme: Targeted Drug Discovery in Neurodegenerative Disorders. Protein Pept Lett  2025,32(8),539-556","journal-title":"Protein Pept Lett"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"102900","DOI":"10.1016\/j.arcmed.2023.102900","volume":"54","author":"Gonz\u00e1lez-Virla B.","year":"2023","unstructured":"Gonz\u00e1lez-Virla B.; Vargas-Ortega G.; Romero-Gameros C.A.; Radiotherapy and Mortality in Pituitary Adenomas. Arch Med Res  2023,54(8),102900","journal-title":"Arch Med Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"Melmed S.","year":"2022","unstructured":"Melmed S.; Kaiser U.B.; Lopes M.B.; Bertherat J.; Syro L.V.; Raverot G.; Reincke M.; Johannsson G.; Beckers A.; Fleseriu M.; Giustina A.; Wass J.A.H.; Ho K.K.Y.; Clinical Biology of the Pituitary Adenoma. Endocr Rev  2022,43(6),1003-1037","journal-title":"Endocr Rev"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11604-023-01400-7","volume":"41","author":"Tsukamoto T.","year":"2023","unstructured":"Tsukamoto T.; Miki Y.; Imaging of pituitary tumors: an update with the 5th WHO Classifications\u2014part 1. Pituitary neuroendocrine tumor (PitNET)\/pituitary adenoma. Jpn J Radiol  2023,41(8),789-806","journal-title":"Jpn J Radiol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3233\/JAD-215707","volume":"88","author":"Toups K.","year":"2022","unstructured":"Toups K.; Hathaway A.; Gordon D.; Chung H.; Raji C.; Boyd A.; Hill B.D.; Hausman-Cohen S.; Attarha M.; Chwa W.J.; Jarrett M.; Bredesen D.E.; Precision Medicine Approach to Alzheimer\u2019s Disease: Successful Pilot Project. J Alzheimers Dis  2022,88(4),1411-1421","journal-title":"J Alzheimers Dis"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"eabm6131","DOI":"10.1126\/science.abm6131","volume":"385","author":"Minhas P.S.","year":"2024","unstructured":"Minhas P.S.; Jones J.R.; Latif-Hernandez A.; Sugiura Y.; Durairaj A.S.; Wang Q.; Mhatre S.D.; Uenaka T.; Crapser J.; Conley T.; Ennerfelt H.; Jung Y.J.; Liu L.; Prasad P.; Jenkins B.C.; Ay Y.A.; Matrongolo M.; Goodman R.; Newmeyer T.; Heard K.; Kang A.; Wilson E.N.; Yang T.; Ullian E.M.; Serrano G.E.; Beach T.G.; Wernig M.; Rabinowitz J.D.; Suematsu M.; Longo F.M.; McReynolds M.R.; Gage F.H.; Andreasson K.I.; Restoring hippocampal glucose metabolism rescues cognition across Alzheimer\u2019s disease pathologies. Science  2024,385(6711),eabm6131","journal-title":"Science"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.2174\/0113892037387954250901202157","volume":"26","author":"Gavade S.","year":"2025","unstructured":"Gavade S.; Dubey S.; Tiwari P.; Benzimidazole Derivatives in Alzheimer\u2019s Therapy: Exploring Multi-Target Pathways. Curr Protein Pept Sci  Epub ahead of print2025,26","journal-title":"Curr Protein Pept Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1093\/brain\/awae292","volume":"147","author":"Koch G.","year":"2024","unstructured":"Koch G.; Altomare D.; Benussi A.; Br\u00e9chet L.; Casula E.P.; Dodich A.; Pievani M.; Santarnecchi E.; Frisoni G.B.; The emerging field of non-invasive brain stimulation in Alzheimer\u2019s disease. Brain  2024,147(12),4003-4016","journal-title":"Brain"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.3390\/ijms26157498","volume":"26","author":"\u0218erban M.","year":"2025","unstructured":"\u0218erban M.; Toader C.; Covache-Busuioc R.A.; The Redox Revolution in Brain Medicine: Targeting Oxidative Stress with AI, Multi-Omics and Mitochondrial Therapies for the Precision Eradication of Neurodegeneration. Int J Mol Sci  2025,26(15),7498","journal-title":"Int J Mol Sci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12888-025-06818-z","volume":"25","author":"Yao K.","year":"2025","unstructured":"Yao K.; Yang L.; Zhang Q.; Li C.; Tian H.; Zhuo C.; Aripiprazole alleviates the high prolactin levels induced by amisulpride via distinct molecular mechanisms: a network pharmacology and molecular docking study. BMC Psychiatry  2025,25(1),373","journal-title":"BMC Psychiatry"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"105932","DOI":"10.5498\/wjp.v15.i10.105932","volume":"15","author":"Zhao J.J.","year":"2025","unstructured":"Zhao J.J.; Han C.Y.; Xu G.X.; Zhou M.; Jin Z.M.; Effect of lurasidone plus sulpiride on treatment efficacy, psychiatric manifestations, and quality of life among patients with schizophrenia. World J Psychiatry  2025,15(10),105932","journal-title":"World J Psychiatry"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajhp\/zxab065","volume":"78","author":"Rusgis M.M.","year":"2021","unstructured":"Rusgis M.M.; Alabbasi A.Y.; Nelson L.A.; Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option. Am J Health Syst Pharm  2021,78(10),862-871","journal-title":"Am J Health Syst Pharm"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"8","DOI":"10.64719\/pb.4493","volume":"54","author":"DeBattista C.","year":"2025","unstructured":"DeBattista C.; Schatzberg A.F.; The Black Book of Psychotropic Dosing and Monitoring. Psychopharmacol Bull  2025,54(3),8-59","journal-title":"Psychopharmacol Bull"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11920-022-01344-1","volume":"24","author":"Jawad M.Y.","year":"2022","unstructured":"Jawad M.Y.; Alnefeesi Y.; Ceban F.; Lui L.M.W.; Jaberi S.; Di Vincenzo J.D.; Amirbeik L.; Chen-Li D.C.J.; Teopiz K.; Phan L.; Cao B.; Ho R.; Rosenblat J.D.; McIntyre R.S.; Lumateperone for the Treatment of Adults With Schizophrenia: a Systematic Review. Curr Psychiatry Rep  2022,24(8),359-368","journal-title":"Curr Psychiatry Rep"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(25)01330-3","volume":"406","year":"2025","unstructured":"Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. Lancet  2025,406(10513),1731-1810","journal-title":"Lancet"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"641560","DOI":"10.3389\/fendo.2021.641560","volume":"12","author":"Effraimidis G.","year":"2021","unstructured":"Effraimidis G.; Watt T.; Feldt-Rasmussen U.; Levothyroxine Therapy in Elderly Patients With Hypothyroidism. Front Endocrinol (Lausanne)  2021,12,641560","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"102497","DOI":"10.1016\/j.arr.2024.102497","volume":"101","author":"Kale M.","year":"2024","unstructured":"Kale M.; Wankhede N.; Pawar R.; Ballal S.; Kumawat R.; Goswami M.; Khalid M.; Taksande B.; Upaganlawar A.; Umekar M.; Kopalli S.R.; Koppula S.; AI-driven innovations in Alzheimer\u2019s disease: Integrating early diagnosis, personalized treatment, and prognostic modelling. Ageing Res Rev  2024,101,102497","journal-title":"Ageing Res Rev"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41582-024-01006-1","volume":"20","author":"Comi G.","year":"2024","unstructured":"Comi G.; Dalla Costa G.; Stankoff B.; Hartung H.P.; Soelberg S\u00f8rensen P.; Vermersch P.; Leocani L.; Assessing disease progression and treatment response in progressive multiple sclerosis. Nat Rev Neurol  2024,20(10),573-586","journal-title":"Nat Rev Neurol"}],"container-title":["Current Neurovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672026467094260417052012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/253637\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672026467094260417052012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:18:25Z","timestamp":1793679505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/253637\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":96,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115672026467094260417052012","relation":{},"ISSN":["1567-2026"],"issn-type":[{"value":"1567-2026","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-11-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}